Literature DB >> 17034469

Muir-Torre syndrome: Diagnostic and screening guidelines.

Brad Jones1, Carol Oh, Elisabeth Mangold, Conleth A Egan.   

Abstract

A 65-year-old man presented with a history of multiple skin coloured papules on his face that were asymptomatic. He had an adenocarcinoma resected from his proximal colon 12 years prior to presentation as well as a family history of colon cancer on the maternal side. Diagnostic biopsies showed the lesions to be sebaceous adenomas and epitheliomas and the diagnosis of Muir-Torre syndrome was made. The sebaceous tumour tissue showed microsatellite instability and immunohistochemical staining indicated diminished expression in the DNA mismatch-repair protein complex MSH2/MSH6. Genetic analysis showed a germline mutation in the MSH2 gene confirming the diagnosis of Muir-Torre syndrome. The patient and his first-degree relatives have been referred for genetic counselling and screening. We review the diagnostic criteria in this syndrome and review the recommended screening guidelines.

Entities:  

Mesh:

Year:  2006        PMID: 17034469     DOI: 10.1111/j.1440-0960.2006.00292.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  9 in total

1.  Muir-Torre Syndrome: expanding the genotype and phenotype--a further family with a MSH6 mutation.

Authors:  H R Murphy; R Armstrong; D Cairns; K L Greenhalgh
Journal:  Fam Cancer       Date:  2008-01-31       Impact factor: 2.375

Review 2.  Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.

Authors:  Sara C Shalin; Stephen Lyle; Eduardo Calonje; Alexander J F Lazar
Journal:  Histopathology       Date:  2010-01       Impact factor: 5.087

3.  p53 staining correlates with tumor type and location in sebaceous neoplasms.

Authors:  Sara C Shalin; Aniket Sakharpe; Stephen Lyle; Dina Lev; Eduardo Calonje; Alexander J Lazar
Journal:  Am J Dermatopathol       Date:  2012-04       Impact factor: 1.533

4.  [Female patient with Muir-Torre syndrome].

Authors:  N Negraszus; K Jöhrens; E Bertelmann
Journal:  Ophthalmologe       Date:  2010-11       Impact factor: 1.059

5.  Muir-Torre Syndrome: A Case Associated with an Infrequent Gene Mutation.

Authors:  Alexandra Grob; Christina Feser; Steven Grekin
Journal:  J Clin Aesthet Dermatol       Date:  2016-01

6.  Muir-Torre syndrome: a case report and screening recommendations.

Authors:  A Pancholi; D Collins; R Lindley; P Gandhi
Journal:  Ann R Coll Surg Engl       Date:  2008-11       Impact factor: 1.891

Review 7.  Familial and genetic risk of transitional cell carcinoma of the urinary tract.

Authors:  Christine M Mueller; Neil Caporaso; Mark H Greene
Journal:  Urol Oncol       Date:  2008-06-18       Impact factor: 3.498

Review 8.  Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?

Authors:  Adele Wong; Joanne Ngeow
Journal:  Biomed Res Int       Date:  2015-06-16       Impact factor: 3.411

9.  Syndrome in question.

Authors:  Catharina Maria Freire de Lucena Pousa; Fernanda Guedes Lavorato; Fernanda Valente Rehfeldt; Danielle Mann; Maria de Fátima Gonçalves Scotelaro Alves
Journal:  An Bras Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.896

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.